Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Women's Health
Published in: BMC Women's Health 1/2017

Open Access 01-12-2017 | Research article

Burden, screening, and treatment of depressive and anxious symptoms among women referred to cardiac rehabilitation: a prospective study

Authors: Megan C. Hurley, Heather M. Arthur, Caroline Chessex, Paul Oh, Karam Turk-Adawi, Sherry L. Grace

Published in: BMC Women's Health | Issue 1/2017

Login to get access

Abstract

Background

Cardiovascular disease (CVD) is one of the leading causes of morbidity and mortality among women. Women with CVD experience a greater burden of psychosocial distress than men, and practice guidelines promote screening in cardiac patients, especially women. The objectives herein were to describe the burden of psychosocial distress, extent of screening, forms of treatment, and whether receipt of treatment was related to psychosocial distress symptom severity at follow-up, among women.

Methods

Within a multi-center trial of women randomized to cardiac rehabilitation models, consenting participants were asked to complete surveys upon consent and 6 months later. Clinical data were extracted from charts. This study presents a secondary analysis of the surveys, including investigator-generated items assessing screening and treatment, the Beck Depression Inventory-II, the Hospital Anxiety and Depression Scale, and Patient Health Questionnaire-2.

Results

Of the 128 (67.0%) participants with valid baseline and follow-up survey results, 48 (40.3%) self-reported that they recalled being screened, and of these, 10 (21.3%) recalled discussing the results with a health care professional. Fifty-six (43.8%) retained participants had elevated symptoms of psychosocial distress at baseline, of which 25 (44.6%) were receiving treatment. Regression analyses showed that treatment of psychosocial distress was not significantly associated with follow-up depressive symptoms, but was significantly associated with greater follow-up anxiety.

Conclusions

Findings reiterate the great burden of psychosocial distress among women with CVD. Less than half of patients with elevated symptoms were treated, and the treatment approaches appeared to insufficiently achieve symptom relief.
Literature
1.
2.
Myers V, Gerber Y, Benyamini Y, Goldbourt U, Drory Y. Post-myocardial infarction depression: Increased hospital admissions and reduced adoption of secondary prevention measures — A longitudinal study. J Psychosom Res. 2012;72(1):5–10.CrossRefPubMed
3.
Lane D, Carroll D, Ring C, Beevers DG, Lip GYH. The prevalence and persistence of depression and anxiety following myocardial infarction. Br J Health Psychol. 2002;7(1):11–21.CrossRefPubMed
4.
Strik JJ, Denollet J, Lousberg R, Honig A. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol. 2003;42(10):1801–7.CrossRefPubMed
5.
Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vacccarino V, Wulsin L. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations. A scientific statement from the American Heart Association. Circulation. 2014;129(12):1350–69.CrossRefPubMed
6.
Grace SL, Abbey SE, Shnek ZM, Irvine J, Franche RL, Stewart DE. Cardiac rehabilitation I: review of psychosocial factors. Gen Hosp Psychiatry. 2002;24(3):121–6.CrossRefPubMed
7.
Lichtman JH, Bigger JT, Blumenthal J, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council of Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768–75.CrossRefPubMed
8.
Green L, Dickinson P, Nease D, Scbellbase K, Campos-Outcalt D, Jeffcott-Pera M. AAFP guideline for the detection and management of post-myocardial infarction depression. Ann Fam Med. 2009;7:71–9.CrossRef
9.
Herridge ML, Stimler CE, Southard DR, King ML. AACVPR position statement – depression screening in cardiac rehabilitation: AACVPR task force report. J Cardiopulm Rehabil Prev. 2005;25(1):11–3.CrossRef
10.
Stone JA, Arthur HM, Suskin N, et al. Canadian Guidelines for Cardiac Rehabilitation and Cardiovascular Disease Prevention:Translating Knowledge into Action. Canadian Association of Cardiac Rehabilitation (3rd ed). Winnipeg: Canadian Association of Cardiac Rehabilitation; 2009.
11.
Elderon L, Whooley MA. Depression and cardiovascular disease. Prog Cardiovasc Dis. 2013;55(6):511–23.CrossRefPubMed
12.
13.
Hollon SD, Stewart MO, Strunk D. Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety. Annu Rev Psychol. 2006;57:285–315.CrossRefPubMed
14.
Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms. Arch Intern Med. 2010;170(7):600–8.CrossRefPubMedPubMedCentral
15.
Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA. 2003;289(23):3106–16.CrossRefPubMed
16.
Glassman AH, O’Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. J Am Med Assoc. 2002;288(6):701–9.CrossRef
17.
Lespérance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. J Am Med Assoc. 2007;297(4):367–79.CrossRef
18.
Thombs BD, de Jonge P, Coyne JC, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. J Am Med Assoc. 2008;300(18):2161–71.CrossRef
19.
Rutledge T, Redwine LS, Linke SE, Mills PJ. A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med. 2013;75(4):335–49.CrossRefPubMed
20.
Gulliksson M, Burell G, Vessby BL, Toss H, Svärdsudd K. Randomized controlled trial of cognitive behavioral therapy vs Standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease. J Am Med Assoc. 2011;171(2):134–40.
21.
Frasure-Smith N, Lesperance F, Prince, et al. Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet. 1997;350(9076):473–9.CrossRefPubMed
22.
Grace SL, Midence L, Oh P, Brister S, Chessex C, Stewart DE, Arthur HM. Cardiac rehabilitation program adherence and functional capacity among women following referral to different program models: A randomized controlled trial. Mayo Clin Proc. 2016;91(2):140–8.CrossRefPubMed
23.
Dillman DA. Mail and internet surveys: the tailored design method. New York: John Wiley; 2000.
24.
Lavie CJ, Milani RV, Cassidy MM, Gilliland YE. Effects of cardiac rehabilitation and exercise training programs in women with depression. Am J Cardiol. 1999;83(10):1480–3.CrossRefPubMed
25.
Martinsen EW. Physical activity in the prevention and treatment of anxiety and depression. Nord J Psychiatry. 2008;62(Suppl 4(10)):25–9.CrossRefPubMed
26.
Godin G, Sheparrd R. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985;10(3):141–6.PubMed
27.
Arnau RC, Meagher MW, Norris MP, Bramson R. Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. Health Psychol. 2001;20(2):112–9.CrossRefPubMed
28.
Bunevicius A, Staniute M, Brozaitiene J, Bunevicius R. Diagnostic accuracy of self-rating scales for screening of depression in coronary artery disease patients. J Psychosom Res. 2012;72(1):22–5.CrossRefPubMed
29.
Kroenke K, Spitzer R, Williams J. The patient health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284–92.CrossRefPubMed
30.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMed
31.
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77.CrossRefPubMed
32.
Mental Health Medications. Washington, DC: U.S Department of Health and Human Services: National Institute of Mental Health; 2010.
33.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.CrossRefPubMed
34.
IBM Corp. IBM SPSS Statistics for Windows, Version 20.0. Armonk: IBM Corp; 2011.
35.
Shanmugasegaram S, Kovacs AH, Oh P, Stewart DE, Grace SL. Patient-recalled incidence of screening and treatment for depression symptoms in coronary artery disease patients. Eur J Cardiovasc Prev Rehabil. 2011;18(Supppl 4):S25.
36.
Katon W, von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care. 1992;30(1):67–76.CrossRefPubMed
37.
Ziegelstein RC, Thombs BD, Coyne JC, de Jonge P. Routine screening for depression in patients with coronary heart disease – never mind. J Am Coll Cardiol. 2009;54(10):886–90.CrossRefPubMedPubMedCentral
38.
Benazon NR, Mamdani MM, Coyne JC. Trends in the prescribing of antidepressants following acute myocardial infarction, 1993-2002. Psychosom Med. 2005;67(6):916–20.CrossRefPubMed
39.
Grace SL, Leung YW, Stewart DE. A prospective examination of antidepressant use and its correlates in patients with acute coronary syndrome. Psychosomatics. 2008;49(3):199–207.CrossRefPubMedPubMedCentral
40.
Amin A, Jones AMH, Nugent K, Rumsfeld JS, Spertus J. The prevalence of unrecognized depression in patients with acute coronary syndrome. Am Heart J. 2006;152(5):928–34.CrossRefPubMed
41.
Thombs BD. No evidence for depression screening in cardiovascular care settings: a comment on CANMAT task force recommendations. Ann Clin Psychiatry. 2012;24(4):319–20. author reply 320–322.PubMed
42.
Cahill M, Bilanovic A, Kelly S, Bacon S, Grace SL. Screening for depression in cardiac rehabilitation: a review. J Cardiopulm Rehabil Prev. 2015;35(4):225–30.CrossRefPubMed
43.
Thomas RJ, King M, Lui K, Oldridge N, Piña IL, Spertus J. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. J Cardiopulm Rehabil. 2007;27(5):260–90.CrossRef
44.
Grace SL, Poirier P, Norris CM, Oakes G, Somanader D, Suskin N. Pan-Canadian development of cardiac rehabilitation and secondary prevention quality indicators. Can J Cardiol. 2014;30(8):945–8.CrossRefPubMed
45.
Huffman JC, Mastromauro CA, Sowden G, Fricchione GL, Healy BC, Januzzi JL. Impact of a depression care management program for hospitalized cardiac patients. Circ Cardiovasc Qual Outcomes. 2011;4(2):198–205.CrossRefPubMed
46.
Rollman BL, Belnap BH. The Bypassing the Blues trial: collaborative care for post-CABG depression and implications for future research. Cleve Clin J Med. 2011;78 Suppl 1:S4–12.CrossRefPubMed
47.
Wade V, Mental P, Care H, Resource A, Cheok F, Program CI, et al. Depression after cardiac hospitalisation. Aust Fam Physician. 2005;34(11):985–9.PubMed
48.
Huffman JC, Mastromauro CA, Beach SR, Celano CM, DuBois CM, Healy BC, Suarez L, Rollman BL, Januzzi JL. Collaborative care for depression and anxiety disorders in patients with recent cardiac events: The Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial. JAMA Intern Med. 2014;174(6):927–35.CrossRefPubMed
49.
Elderon L, Smolderen KG, Na B, Whooley MA. Accuracy and prognostic value of American Heart Association - recommended depression screening in patients with coronary heart disease: Data from the Heart and Soul Study. Circ Cardiovasc Qual Outcomes. 2011;4(5):533–40.CrossRefPubMed
50.
van de Mortel T. Faking it : social desirability response bias in self- report research report research. Aust J Adv Nurs. 2008;25(4):40–8.
51.
Hunt M, Auriemma J, Cashaw ACA. Self-report bias and underreporting of depression on the BDI-II. J Pers Assess. 2003;80(1):26–30.CrossRefPubMed
52.
Beckie TM, Beckstead JW. The effects of a cardiac rehabilitation program tailored for women on their perceptions of health: a randomized clinical trial. J Cardiopulm Rehabil Prev. 2012;31(1):25–34.CrossRef
Metadata
Title
Burden, screening, and treatment of depressive and anxious symptoms among women referred to cardiac rehabilitation: a prospective study
Authors
Megan C. Hurley
Heather M. Arthur
Caroline Chessex
Paul Oh
Karam Turk-Adawi
Sherry L. Grace
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2017
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-017-0367-1

Other articles of this Issue 1/2017

BMC Women's Health 1/2017 Go to the issue

Case report

Case report: term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix

Research article

Trichomoniasis and associated co-infections of the genital tract among pregnant women presenting at two hospitals in Ghana

Research article

Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study

Research article

Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status

Research article

Characteristics of cervical disease among symptomatic women with histopathological sample at Hawassa University referral hospital, Southern Ethiopia

Research article

Implications of male circumcision for women in Papua New Guinea: a transformational grounded theory study